Modulation of induced resistance to adriamycin in two human breast cancer cell lines with tamoxifen or perhexiline maleate
Data up to Jan 2025
Total Citations Per Year
Abstract
References (27)
A Human Cell Line From a Pleural Effusion Derived From a Breast Carcinoma 2
1973 • 2,431 citations
[Cancer of the breast].
1962 • 940 citations
Increased accumulation of vincristine and adriamycin in drug-resistant P388 tumor cells following incubation with calcium antagonists and calmodulin inhibitors.
1982 • 667 citations
Reversal of Adriamycin Resistance by Verapamil in Human Ovarian Cancer
1984 • 398 citations
Randomized Clinical Trial of Diethylstilbestrol versus Tamoxifen in Postmenopausal Women with Advanced Breast Cancer
1981 • 334 citations
Treatment of Primary Breast Cancer with Chemotherapy and Tamoxifen
1981 • 289 citations
A randomized comparative trial of adriamycin versus methotrexate in combination drug therapy
1978 • 236 citations
Reversal of acquired resistance to doxorubicin in P388 murine leukemia cells by tamoxifen and other triparanol analogues.
1984 • 182 citations
Effect of modification of plasma membrane fatty acid composition on fluidity and methotrexate transport in L1210 murine leukemia cells.
1979 • 139 citations
In vivo characteristics of resistance and cross-resistance of an adriamycin-resistant subline of P388 leukemia.
1978 • 135 citations
Cross resistance between vinca alkaloids and anthracyclines in Ehrlich ascites tumor in vivo.
1972 • 115 citations
Tamoxifen therapy in premenopausal patients with metastatic breast cancer.
1980 • 107 citations
Plasma membrane lipid structural order in doxorubicin-sensitive and -resistant P388 cells.
1983 • 106 citations
Increased resistance to chlorambucil in cultured cells with a high concentration of cytoplasmic metallothionein.
1983 • 83 citations
Reversal of acquired resistance to doxorubicin in P388 murine leukemia cells by perhexiline maleate.
1984 • 79 citations
Cloning of human ovarian cancer cells in soft agar from malignant and peritoneal washings.
1980 • 73 citations
Mechanism of Cellular Drug Resistance
1971 • 72 citations
The metabolism of cytosine arabinoside as a predictive test for clinical response to the drug in acute myeloid leukaemia
1976 • 63 citations
Differences in lipid composition of doxorubicin-sensitive and -resistant P388 cells.
1984 • 62 citations
Resistance and Cross-Resistance of Cultured Leukemia P388 Cells to Vincristine, Adriamycin, Adriamycin Analogs, and Actinomycin D<xref ref-type="fn" rid="FN2">2</xref>
1978 • 57 citations
Dibromodulcitol and Adriamycin ± tamoxifen in advanced breast cancer*
1982 • 55 citations
Enhanced glycosylation induced by adriamycin.
1979 • 53 citations
Combination chemotherapy for advanced breast cancer.Two regimens containing adriamycin
1978 • 28 citations
Enhancement of doxorubicin and vinblastine sensitivity in anthracycline-resistant P388 cells.
1983 • 27 citations
Biochemical Parameters of Resistance of an Adriamycin-Resistant Subline of P388 Leukemia to Emetine, an Inhibitor of Protein Synthesis
1978 • 26 citations
Symposium on cellular resistance to anticancer drugs. Introduction.
1983 • 9 citations
Modification of in vivo methotrexate antitumor effect in L1210 leukemia by induced impairment of purine salvage
1981 • 7 citations